Achim Prof. Dr. Aigner – Professor – University of Leipzig, Rudolf-Boehm-Institute for Pharmacology and Toxicology | LinkedIn
Loop | Achim Aigner
Leipziger Pharmakologen forschen an Molekülen gegen Prostatakrebs
Neuartige Gentherapie zur Behandlung des Glioblastoms
SiSaf and the University of Leipzig Partner to Develop
Aktuelles
Rudolf-Boehm-Institut für Pharmakologie und Toxikologie
Mitarbeiter des Rudolf-Boehm-Institutes
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Analysis of SATB1 in Head and Neck Squamous Cell Carcinoma
Wissenschaftlicher Beirat – Frankfurt Foundation Quality of Medicines
Mitarbeiter des Rudolf-Boehm-Institutes
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Partnership will develop targeted miRNAs to treat pancreatic cancer - Drug Discovery World (DDW)
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Mitarbeiter des Rudolf-Boehm-Institutes
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Mitarbeiter des Rudolf-Boehm-Institutes
Pancreatic Cancer Therapy Using miRNA
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Wissenschaftlicher Mitarbeiter (m/w/d) Klinische Pharmakologie - Universität Leipzig, Medizinische Fakultät - academics
Björn Simon
